Drugdiscovery >> Clinical Trials >> News
4675
Views
Removing Lymph Node Helps to Cure Breast Cancer? - drugdiscovery.com
Removing Lymph Node Helps to Cure Breast Cancer? - drugdiscovery.com


Less removal of lymph nodes is needed according to the new results of scientists. Formerly, when treating breast cancer, all the lymph nodes were removed in order to prevent the injured cells spread in the body. They found out that in some cases there is no need for that.
Read More >>


Tags: cell, cancer, breast cancer - October 11, 2013
Related Articles
4500
Views
T-DM1 drug beneficial for patients with advanced HER2 positive breast cancer T-DM1 drug beneficial for patients with advanced HER2 positive breast cancer
The results of the Phase 3 TH3RESA trial show that T-DM1, a conjugated monoclonal antibody in which trastuzumab is combined with a cell-killing drug emtansine (DM1), significantly improves the length Read More >>

Tags: T-DM1, breast cancer, advanced breast cancer, HER2 positive, combination drug, trastuzumab, emtansine, clinical trial

3192
Views
Lilly’s cancer drug unsuccessful in breast cancer trial but shows promise in gastric cancer treatment Lilly’s cancer drug unsuccessful in breast cancer trial but shows promise in gastric cancer treatment
Eli Lilly’s investigational drug ramucirumab, missed its main goal in a late-stage study in patients with advanced breast cancer. The drug performed better in a separate study in patients with advan Read More >>

Tags: Eli Lilly, Lilly, investigational drug, clinical trials, ramucirumab, breast cancer, gastric cancer

3396
Views
Cancer research UK and its phamraceutical partner gain success Cancer research UK and its phamraceutical partner gain success
The clinical trial of Cancer research UK and its partners, such as AstraZeneca and Pfizer proved to be an outstanding success. The promising clinical trials offer a new help for lung cancer treatment. Read More >>

Tags: lung cancer, treatment, cancer research, cancer research UK

4661
Views
Ovarian cancer drug demcizumab enters Phase 2 Ovarian cancer drug demcizumab enters Phase 2
OncoMed Pharmaceuticals’ stem cell product candidate, demcizumab (OMP-21M18) has entered Phase 1b/2 clinical trial and will be tested in combination with paclitaxel in patients with platinum-resista Read More >>

Tags: OncoMed, oncomed, demcizumab, ovarian cancer, fallopian tube cancer, primary peritoneal cancer

4181
Views
GSK has ended the trials of its new lung cancer treatment GSK has ended the trials of its new lung cancer treatment
Phase 3 trial of its MAGE-A3 was reported to be finished by GlaxoSmithKline. They say it is impossible to make sure that the drug is effective against non-small-cell lung cancer. Read More >>

Tags: GSK clinical trial., MAGE-A3, lung cancer, lung cancer drug, lung cancer drug development

3428
Views
New clinical trial in ovarian cancer New clinical trial in ovarian cancer
Adaptimmune has opened a Phase I/IIa clinical trial at Roswell Park Cancer Institute (RPCI) in Buffalo, N.Y., and City of Hope (COH) in Duarte, Calif. The patients will be treated with their own T ce Read More >>

Tags: ovarian cancer, T cells, cancer immunotherapy, TCR enhancement technology, CT antigens

5511
Views
Sidney Kimmel Comprehensive Cancer Center sponsors Phase II. trial of MK-3475 Sidney Kimmel Comprehensive Cancer Center sponsors Phase II. trial of MK-3475
Sidney Kimmel Comprehensive Cancer Center sponsors the phase II clinical trial of a new medicine which is used for treating MSI Positive Colorectal Cancer. Read More >>

Tags: MSI Positive Colorectal Cancer, cancer, Sidney Kimmel Comprehensive Cancer Center

3165
Views
Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer
Merck Serono’s Erbitux (cetuximab) plus FOLFIRI, compared to bevacizumab plus FOLFIRI, has shown a clinically relevant improvement (7.5 month increase in median overall survival) as first-line tr Read More >>

Tags: Erbitux, cetuximab, clinical trail, metastatic, colorectal cancer, Merck, cancer therapy

17764
Views
Autologous immune cell therapy tested in liver cancer patients Autologous immune cell therapy tested in liver cancer patients
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of proprietary cell therapies for certain degenerative and malignant diseases, announced positive results from its phase Read More >>

Tags: cancer stem cell, dendritic cell, immunotherapy, liver cancer, phase I trial, liver cancer, hepatocellular carcinoma, HCC, clinical trial, immune cells, therapy, dendritic cells

4291
Views
Merck continues the clinical development of tecemotide for lung cancer Merck continues the clinical development of tecemotide for lung cancer
Tecemotide (also known as L-BLP25), an investigational MUC1 antigen-specific cancer immunotherapy will be tested in a new Phase 3 trial called START for patients with unresectable, locally advanced S Read More >>

Tags: Merck, tecemotide, lung cancer, non-small cell lung cancer, immunotherapy

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013